[go: up one dir, main page]

WO2009152986A8 - Muc16 fragments with antigenic activity and pharmaceutical compositions thereof - Google Patents

Muc16 fragments with antigenic activity and pharmaceutical compositions thereof Download PDF

Info

Publication number
WO2009152986A8
WO2009152986A8 PCT/EP2009/004168 EP2009004168W WO2009152986A8 WO 2009152986 A8 WO2009152986 A8 WO 2009152986A8 EP 2009004168 W EP2009004168 W EP 2009004168W WO 2009152986 A8 WO2009152986 A8 WO 2009152986A8
Authority
WO
WIPO (PCT)
Prior art keywords
fragments
pharmaceutical compositions
muc16
antigenic activity
antigenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2009/004168
Other languages
French (fr)
Other versions
WO2009152986A1 (en
Inventor
Cristina Goso
Valentina Fedi
Carlo Alberto Maggi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Menarini International Operations Luxembourg SA
Original Assignee
Menarini International Operations Luxembourg SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menarini International Operations Luxembourg SA filed Critical Menarini International Operations Luxembourg SA
Publication of WO2009152986A1 publication Critical patent/WO2009152986A1/en
Publication of WO2009152986A8 publication Critical patent/WO2009152986A8/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4727—Mucins, e.g. human intestinal mucin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

There are disclosed pharmaceutical compositions containing MUC 16 fragments with antigenic activity and their use for the preparation of antitumor vaccines.
PCT/EP2009/004168 2008-06-19 2009-06-10 Muc16 fragments with antigenic activity and pharmaceutical compositions thereof Ceased WO2009152986A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI20081119 ITMI20081119A1 (en) 2008-06-19 2008-06-19 FRAGMENTS OF MUC16 WITH ANTIGENIC ACTIVITY AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
ITMI2007A001119 2008-06-19
ITMI2008A001119 2008-06-19

Publications (2)

Publication Number Publication Date
WO2009152986A1 WO2009152986A1 (en) 2009-12-23
WO2009152986A8 true WO2009152986A8 (en) 2010-03-04

Family

ID=40301828

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2009/004168 Ceased WO2009152986A1 (en) 2008-06-19 2009-06-10 Muc16 fragments with antigenic activity and pharmaceutical compositions thereof

Country Status (2)

Country Link
IT (1) ITMI20081119A1 (en)
WO (1) WO2009152986A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201507030D0 (en) * 2015-04-24 2015-06-10 Immatics Biotechnologies Gmbh Immunotherapy against lung cancers, in particular NSCLC

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8404803B2 (en) * 2005-03-31 2013-03-26 Chugai Seiyaku Kabushiki Kaisha Cancer-associated antigen analogue peptides and uses thereof

Also Published As

Publication number Publication date
WO2009152986A1 (en) 2009-12-23
ITMI20081119A1 (en) 2009-12-20

Similar Documents

Publication Publication Date Title
IL219876A (en) Antibody or fragment thereof against human b7-h1, compositions comprising same and use thereof in the preparation of medicaments
IL206952A (en) Aminodihydrothiazine derivatives, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments
IL213019A (en) 1-aza-3-heteroaryl-azulene derivatives, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments
ZA201101477B (en) Co-crystals and pharmaceutical formulations comprising the same
IL218490A (en) Substituted dihydro benzocycloalkyloxymethyl oxazolopyrimidinones, compositions comprising the same and use thereof in the preparation of pharmaceutical compositions
IL234166B (en) Isoindoline compounds, pharmaceutical compositions comprising the same and use thereof in the preparation of medicaments
EP4434550A3 (en) Human antibody drug conjugates against tissue culture
WO2008128115A3 (en) Low-dose doxepin formulations
IL215065A (en) Proline derivatives, process for their preparation, pharmaceutical compositions comprising said derivatives and use thereof for the preparation of medicaments
WO2008132229A3 (en) Highly concentrated insulin solutions and compositions
EP2143724A4 (en) Nitrogenated fused ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes
EP3626253A3 (en) Stable formulations of linaclotide
IL211842A (en) Antibody or human tgfbrii-binding fragment thereof, pharmaceutical compositions comprising them and use thereof in the manufacture of medicaments for inhibiting angiogenesis
WO2010021607A3 (en) Pharmaceutical formulation
IL207684A (en) Substituted indole derivatives, process for the preparation of the derivatives, medicinal products comprising the same and their use in the preparation of medicinal products
IL206562A0 (en) Novel catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition
GB0903158D0 (en) Cosmetic or pharmaceutical preparation for the skin
AU2011352504A1 (en) Moisture-retaining chinese herbal medicine composition and preparation method and use thereof
EP2261221A4 (en) Epothilone analogues, their pharmaceutical compositions, their use and their preparations
SG10201403149YA (en) Novel 1,2,3,4-tetrahydro-pyrimido(1,2-a)pyrimidin-6-one derivatives, preparation thereof and pharmaceutical use thereof
WO2011002422A3 (en) Solubility enhancing pharmaceutical formulation
IL209698A (en) Use of nifurtimox for the preparation of pharmaceuticals and compositions comprising said nifurtimox
HK1199841A1 (en) Acamprosate formulations, methods of using the same, and combinations comprising the same
WO2010036344A3 (en) Compositions, oral care products and methods of making and using the same
WO2009152986A8 (en) Muc16 fragments with antigenic activity and pharmaceutical compositions thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09765566

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09765566

Country of ref document: EP

Kind code of ref document: A1